4401 - 4425 of 8587 Results
Title
Year
- The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)2013RESTRICTEDTitle: The Coalition Against Major Diseases: Dopamine Transporter Neuroimaging as an Enrichment Biomarker To Enable Parkinson's Disease Clinical Trials (P06.049)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 7_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.80.7_supplement.p06.049Citation Count: 2
- Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive Immunoassay2019OPENTitle: Phospho-S129 Alpha-Synuclein Is Present in Human Plasma but Not in Cerebrospinal Fluid as Determined by an Ultrasensitive ImmunoassayJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2019.00889Best OA location URL: https://doi.org/10.3389/fnins.2019.00889Citation Count: 43
- Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors2011RESTRICTEDTitle: Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitorsJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 64Issue #: 3Start Page: 268End Page: 273Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2011.03.017Citation Count: 52
-
OPENTitle: Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 1Start Page: 178End Page: 187Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28299Citation Count: 45
- Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementia2018OPENTitle: Human cerebral collateral arteriole function in subjects with normal cognition, mild cognitive impairment, and dementiaJournal Name: American Journal of Physiology-Heart and Circulatory PhysiologyPublisher: American Physiological SocietyVol: 315Issue #: 2Start Page: H284End Page: H290Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/ajpheart.00206.2018Best OA location URL: https://journals.physiology.org/doi/pdf/10.1152/ajpheart.00206.2018Citation Count: 12
- Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner2017RESTRICTEDTitle: Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent mannerJournal Name: Biochimica et Biophysica Acta (BBA) - General SubjectsPublisher: Elsevier BVVol: 1861Issue #: 4Start Page: 922End Page: 935Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbagen.2017.01.021Citation Count: 18
-
OPENTitle: Fidelity of frequency and phase entrainment of circuit-level spike activity during DBSJournal Name: Journal of NeurophysiologyPublisher: American Physiological SocietyVol: 114Issue #: 2Start Page: 825End Page: 834Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1152/jn.00259.2015Best OA location URL: http://doi.org/10.1152/jn.00259.2015Citation Count: 47
- Molecular rotors report on changes in live cell plasma membrane microviscosity upon interaction with beta-amyloid aggregates2018RESTRICTEDTitle: Molecular rotors report on changes in live cell plasma membrane microviscosity upon interaction with beta-amyloid aggregatesJournal Name: Soft MatterPublisher: Royal Society of Chemistry (RSC)Vol: 14Issue #: 46Start Page: 9466End Page: 9474Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1039/c8sm01633jBest OA location URL: http://spiral.imperial.ac.uk/bitstream/10044/1/65822/2/manuscript_final%20plus%20methods.pdfCitation Count: 40
- Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB2018OPENTitle: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 115Issue #: 51Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1073/pnas.1813365115Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdfCitation Count: 77
- TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated mice2007OPENTitle: TNF-α knockout and minocycline treatment attenuates blood–brain barrier leakage in MPTP-treated miceJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 26Issue #: 1Start Page: 36End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2006.11.012Best OA location URL: http://doi.org/10.1016/j.nbd.2006.11.012Citation Count: 166
- A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium Channels2020OPENTitle: A Single Amino Acid Determines the Selectivity and Efficacy of Selective Negative Allosteric Modulators of CaV1.3 L-Type Calcium ChannelsJournal Name: ACS Chemical BiologyPublisher: American Chemical Society (ACS)Vol: 15Issue #: 9Start Page: 2539End Page: 2550Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschembio.0c00577Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7502546Citation Count: 17
-
OPENTitle: Deep Brain Stimulation in a Case of Mitochondrial DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 3Issue #: 2Start Page: 139End Page: 145Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12241Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12241Citation Count: 9
-
OPENTitle: Minimal Clinically Important Difference for UPDRS‐III in Daily PracticeJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 5Issue #: 4Start Page: 448End Page: 450Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12632Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12632Citation Count: 46
-
RESTRICTEDTitle: Enteric alpha-synuclein pathology in LRRK2-G2019S Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 40Issue #:Start Page: 83End Page: 84Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.05.001Citation Count: 7
-
RESTRICTEDTitle: Disease-modifying therapies for Parkinson's diseaseJournal Name: The Biomedical & Life Sciences CollectionPublisher: Henry Stewart TalksVol: 2013Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.69645/krxj9755Citation Count: 0
-
OPENTitle: Comparison of two protocols for the generation of iPSC-derived human astrocytesJournal Name: Biological Procedures OnlinePublisher: Springer Science and Business Media LLCVol: 25Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12575-023-00218-xBest OA location URL: https://biologicalproceduresonline.biomedcentral.com/counter/pdf/10.1186/s12575-023-00218-xCitation Count: 6
- Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET Radioligand2024OPENTitle: Identification and In Vitro and In Vivo Characterization of KAC-50.1 as a Potential α-Synuclein PET RadioligandJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 15Issue #: 22Start Page: 4210End Page: 4219Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acschemneuro.4c00493Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.4c00493Citation Count: 1
- Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian rats2013OPENTitle: Effects of prolonged selective serotonin reuptake inhibition on the development and expression of l-DOPA-induced dyskinesia in hemi-parkinsonian ratsJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 77Issue #:Start Page: 1End Page: 8Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2013.09.017Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3865178Citation Count: 63
- Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestoration2010OPENTitle: Effects of intrastriatal GDNF on the response of dopamine neurons to 6-hydroxydopamine: Time course of protection and neurorestorationJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1370Issue #:Start Page: 80End Page: 88Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.brainres.2010.11.006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3019295Citation Count: 41
- Discordance Between Balance Ability and Perception Is Associated With Falls in Parkinson’s Disease: A Coordinated Analysis2024RESTRICTEDTitle: Discordance Between Balance Ability and Perception Is Associated With Falls in Parkinson’s Disease: A Coordinated AnalysisJournal Name: Neurorehabilitation and Neural RepairPublisher: SAGE PublicationsVol: 39Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/15459683241300456Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11850210Citation Count: 2
- Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonism2022OPENTitle: Soluble urokinase-type plasminogen activator receptor (suPAR) is elevated in caregivers of patients with parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 39End Page: 42Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.019Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.06.019Citation Count: 1
- Protocol to measure centrosome cohesion deficits mediated by pathogenic LRRK2 in cultured cells using confocal microscopy2023OPENTitle: Protocol to measure centrosome cohesion deficits mediated by pathogenic LRRK2 in cultured cells using confocal microscopyJournal Name: STAR ProtocolsPublisher: Elsevier BVVol: 4Issue #: 1Start Page: 102024End Page: 102024Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.xpro.2022.102024Best OA location URL: https://doi.org/10.1016/j.xpro.2022.102024Citation Count: 6
-
RESTRICTEDTitle: End of life planning in parkinsonian diseasesJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 62Issue #:Start Page: 73End Page: 78Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.01.026Citation Count: 9
-
RESTRICTEDTitle: The meaning of a “hippo” response on the Montreal Cognitive Assessment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 19Issue #: 4Start Page: 463End Page: 465Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2012.09.005Citation Count: 1
- Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson's disease2020RESTRICTEDTitle: Longitudinal evolution of non-motor symptoms according to age at onset in early Parkinson's diseaseJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 418Issue #:Start Page: 117157End Page: 117157Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2020.117157Citation Count: 16